Published: Thu, February 15, 2018
Business | By Tara Barton

Venturi Wealth Management LLC Sells 12470 Shares of AbbVie Inc (ABBV)


Great West Life Assurance Company who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $180.52B market cap company. The stock increased 0.22% or $0.24 during the last trading session, reaching $113.32. About 86,883 shares traded.

AbbVie (NYSE:ABBV) last posted its earnings results on Friday, January 26th. It has outperformed by 1.89% the S&P500.

Finemark National Bank & Trust decreased Abbvie Inc (ABBV) stake by 4.54% reported in 2017Q3 SEC filing. Gradient Investments Llc sold 34,157 shares as the company's stock rose 7.02% with the market. The Blue Chip Partners Inc holds 94,836 shares with $8.43 million value, up from 90,933 last quarter. Abbvie now has $182.33B valuation.

The stock decreased 0.85% or $0.05 during the last trading session, reaching $5.85. About 520,708 shares traded.

Microsoft Surface Phone Featuring Snapdragon 845 On The Way
At this point, it's not clear exactly how the "Windows App Previews" scheme will work, or even if it will happen. So, Microsoft's CEO Satya Nadella dropped the mantra of "Mobile-first" and adopted the new one; "Cloud-first".

NWQ Investment Management Company LLC trimmed its position in AbbVie Inc (NYSE:ABBV) by 23.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. It has underperformed by 6.07% the S&P500.

Investors sentiment decreased to 0.85 in 2017 Q3. The company reported $1.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.44 by $0.04. It increased, as 77 investors sold T shares while 609 reduced holdings. 848.03 million shares or 4.66% less from 889.52 million shares in 2017Q2 were reported. Zeke Capital Limited Liability stated it has 25,493 shares or 0.31% of all its holdings. (NYSE:ABBV) for 828,461 shares. Symphony Asset Management Limited Com holds 0.03% or 16,529 shares in its portfolio. Moreover, Fcg Advisors Lc has 0.4% invested in AT&T Inc. Advantus Mgmt invested in 120,471 shares. Amica Mutual Insurance invested in 0.67% or 84,346 shares. First City Cap Mngmt has invested 0.66% in 3M Company (NYSE:MMM). American Asset Mngmt reported 5,266 shares or 0.29% of all its holdings. Cape Cod Five Cents Bank & Trust invested in 30,433 shares or 0.42% of the stock. Associated Banc has invested 0.88% in 3M Company (NYSE:MMM). (NYSE:ABBV). Perella Weinberg Prtn Capital Lp holds 22,624 shares. Blb&B Advisors Ltd Llc has 1.83% invested in 3M Company (NYSE:MMM) for 56,529 shares. Schulhoff holds 0.14% or 15,920 shares. Following the transaction, the chairman now owns 492,030 shares in the company, valued at approximately $46,255,740.30. About 133,534 shares traded. It also reduced On Semiconductor Corp (Prn) stake by 2.00 million shares and now owns 11.10 million shares. Eog Res Inc (NYSE:EOG) was reduced too. (NYSE:T), 10 have Buy rating, 1 Sell and 19 Hold. Therefore 26% are positive. AT&T Inc. had 73 analyst reports since July 27, 2015 according to SRatingsIntel. The company was maintained on Wednesday, October 25 by Deutsche Bank. (NYSE:ABBV) has "Hold" rating given on Thursday, July 20 by Credit Suisse. (NYSE:ABBV) earned "Market Perform" rating by BMO Capital Markets on Thursday, November 16. Deutsche Bank maintained the stock with "Hold" rating in Tuesday, August 25 report. The stock has "Market Perform" rating by BMO Capital Markets on Friday, June 10. The firm has "Neutral" rating by Piper Jaffray given on Wednesday, November 16. The stock presently has an average rating of "Buy" and an average price target of $117.26. The stock of The Medicines Company (NASDAQ:MDCO) earned "Buy" rating by Chardan Capital Markets on Monday, March 21.

Investors sentiment increased to 1.17 in 2017 Q3. Its down 0.15, from 1 in 2017Q2.

Several other institutional investors and hedge funds have also modified their holdings of ABBV. 132 funds opened positions while 462 raised stakes. Invest Centers Of America holds 0.44% of its portfolio in AbbVie Inc. Moreover, Advisory Network Ltd Liability Company has 0.4% invested in AbbVie Inc. (NYSE:ABBV). Outfitter Advsrs Ltd reported 5,041 shares. 195,098 are held by Gofen And Glossberg Limited Liability Company Il. Long Road Inv Counsel Limited Liability stated it has 12,994 shares. 387,638 are owned by Dana Inv Advsr Incorporated. (NYSE:ABBV). Compton Mgmt Ri owns 27,004 shares or 1.08% of their USA portfolio. (NYSE:ABBV). Commonwealth State Bank Of Australia holds 127,750 shares. Hilton Ltd Company has 0.07% invested in AbbVie Inc. The shares were sold at an average price of $98.45, for a total transaction of $8,569,088.00. Electron Capital Partners Llc sold 5,122 shares as Pampa Energia S A (PAM)'s stock rose 26.59%. RICHMOND TIMOTHY J. sold $8.57M worth of stock or 87,040 shares. On Monday, September 11 the insider SALEKI-GERHARDT AZITA sold $705,655. (NYSE:ABBV). Synovus Corp has 165,777 shares. Gosebruch Henry O had sold 18,300 shares worth $1.66M. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. Therefore 48% are positive. AbbVie's revenue was up 13.9% on a year-over-year basis. analysts predict that AbbVie Inc will post 7.46 EPS for the current year. The firm has "Equal-Weight" rating by Barclays Capital given on Tuesday, December 1. The firm has "Buy" rating by Jefferies given on Monday, May 29. On Monday, December 5 the stock rating was initiated by H.C. Wainwright with "Buy". Goldman Sachs downgraded AbbVie Inc. The rating was upgraded by Cowen & Co on Wednesday, October 11 to "Outperform". Zacks Investment Research lowered shares of AbbVie from a "buy" rating to a "hold" rating in a research note on Friday, October 20th. Beaton Management Co. Inc. acquired a new position in shares of AbbVie during the second quarter worth $528,000. (NYSE:ABBV) for 18,149 shares. TheStreet upgraded the stock to "Buy" rating in Tuesday, August 11 report. On Friday, February 2 the stock rating was maintained by Argus Research with "Buy". UBS maintained 3M Company (NYSE:MMM) on Friday, July 24 with "Buy" rating.

Like this: